News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Filippo Pietrantonio: Vorbipiprant with PD-1 Blockade for Refractory MSS Metastatic Colorectal Cancer
Filippo Pietrantonio/X
Dec 4, 2024, 06:28

Filippo Pietrantonio: Vorbipiprant with PD-1 Blockade for Refractory MSS Metastatic Colorectal Cancer

Filippo Pietrantonio, GI medical oncologist at the National Cancer Institute of Milan, shared a post on X about a recent paper by him and colleagues published in Clinical Cancer Research:

“The Prostaglandin EP4 Antagonist Vorbipiprant Combined with PD-1 Blockade for Refractory Microsatellite Stable Metastatic Colorectal Cancer: A Phase 1b/2a Trial.”

Authors: Filippo Pietrantonio, Federica Morano, Monica Niger, Federica Girolami, Lucio Rovati et al.

Filippo Pietrantonio: Vorbipiprant with PD-1 Blockade for Refractory MSS Metastatic Colorectal Cancer

More posts featuring Filippo Pietrantonio.

cancer Federica Girolami Federica Morano Filippo Pietrantonio Lucio Rovati Metastatic colorectal cancer Monica Niger OncoDaily Oncology Vorbipiprant
Special Coverage
Insight
Dec 4, 2024, 06:28
Filippo Pietrantonio: Vorbipiprant with PD-1 Blockade for Refractory MSS Metastatic Colorectal Cancer
Blog
Dec 4, 2024, 06:19
Giannis Mountzios: Main actions to boost lung cancer research and innovation
Blog
Dec 4, 2024, 00:18
The blueprint summary of European Cancer Organisation's smartCARE app
Opinion
Dec 4, 2024, 00:12
Giannis Mountzios: A must-read Review on the ever-evolving field of EGFR mut NSCLC
Blog
Dec 4, 2024, 00:09
Michael Jefford: Special session on cancer survivorship at ESMO Asia 2024
Blog
Dec 4, 2024, 00:00
ESMO - Practice-changing publications in NSCLC and endometrial cancer critically reviewed by leading experts
Insight
Dec 3, 2024, 19:29
James Wu: Food insecurity in the Asian-American community
Blog
Dec 3, 2024, 19:26
Fumiko Ladd Chino: Donate for kids living with hunger in the US
Insight
Dec 3, 2024, 19:22
Matthew Katz: Consensus-based OAR dose constraint and target goal templates for lung cancer radiation therapy
Insight
Dec 3, 2024, 19:18
Shivani Modi: Findings from the ESOPEC trial for enhanced treatment approaches in esophageal adenocarcinoma
Blog
Dec 3, 2024, 19:14
Alan H Bryce: The manuscript from the 2024 United States Prostate Cancer Consensus Conference
Blog
Dec 3, 2024, 19:10
Does the target of enfortumab vedotin play a significant role in the treatment of bladder cancer?